241 related articles for article (PubMed ID: 11986947)
1. A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand.
Costello RT; Sivori S; Mallet F; Sainty D; Arnoulet C; Reviron D; Gastaut JA; Moretta A; Olive D
Leukemia; 2002 May; 16(5):855-60. PubMed ID: 11986947
[TBL] [Abstract][Full Text] [Related]
2. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
3. Distinct granzyme expression in human CD3- CD56+ large granular- and CD3- CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity.
Smyth MJ; Browne KA; Kinnear BF; Trapani JA; Warren HS
J Leukoc Biol; 1995 Jan; 57(1):88-93. PubMed ID: 7530284
[TBL] [Abstract][Full Text] [Related]
4. Relationship of large and small CD3- CD56+ lymphocytes mediating NK-associated activities.
Ortaldo JR; Winkler-Pickett R; Kopp W; Kawasaki A; Nagashima K; Okumura K; Yagita H; Bach FH
J Leukoc Biol; 1992 Sep; 52(3):287-95. PubMed ID: 1381742
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: the NK cell receptor 2B4 augments antigen-specific T cell cytotoxicity through CD48 ligation on neighboring T cells.
Lee KM; Bhawan S; Majima T; Wei H; Nishimura MI; Yagita H; Kumar V
J Immunol; 2003 May; 170(10):4881-5. PubMed ID: 12734329
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell.
Linn YC; Lau SK; Liu BH; Ng LH; Yong HX; Hui KM
Immunology; 2009 Mar; 126(3):423-35. PubMed ID: 18778291
[TBL] [Abstract][Full Text] [Related]
7. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
Dhanji S; Teh HS
J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
[TBL] [Abstract][Full Text] [Related]
8. 2B4-mediated activation of human natural killer cells.
Tangye SG; Cherwinski H; Lanier LL; Phillips JH
Mol Immunol; 2000 Jun; 37(9):493-501. PubMed ID: 11163399
[TBL] [Abstract][Full Text] [Related]
9. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells.
McNerney ME; Lee KM; Kumar V
Mol Immunol; 2005 Feb; 42(4):489-94. PubMed ID: 15607804
[TBL] [Abstract][Full Text] [Related]
10. 2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.
Ostrowski SR; Ullum H; Pedersen BK; Gerstoft J; Katzenstein TL
Clin Exp Immunol; 2005 Sep; 141(3):526-33. PubMed ID: 16045743
[TBL] [Abstract][Full Text] [Related]
11. Activating interactions in human NK cell recognition: the role of 2B4-CD48.
Nakajima H; Cella M; Langen H; Friedlein A; Colonna M
Eur J Immunol; 1999 May; 29(5):1676-83. PubMed ID: 10359122
[TBL] [Abstract][Full Text] [Related]
12. The murine NK receptor 2B4 (CD244) exhibits inhibitory function independent of signaling lymphocytic activation molecule-associated protein expression.
Mooney JM; Klem J; Wülfing C; Mijares LA; Schwartzberg PL; Bennett M; Schatzle JD
J Immunol; 2004 Sep; 173(6):3953-61. PubMed ID: 15356144
[TBL] [Abstract][Full Text] [Related]
13. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
[TBL] [Abstract][Full Text] [Related]
14. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
15. 2B4/CD48-mediated regulation of lymphocyte activation and function.
Assarsson E; Kambayashi T; Persson CM; Chambers BJ; Ljunggren HG
J Immunol; 2005 Aug; 175(4):2045-9. PubMed ID: 16081768
[TBL] [Abstract][Full Text] [Related]
16. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
17. Role of T-cell antigens in the cytolytic activities of large granular lymphocytes (LGLs) in patients with LGL lymphocytosis.
Oshimi K; Oshimi Y; Akahoshi M; Kobayashi Y; Hirai H; Takaku F; Hattori M; Asano S; Kodo H; Nishinarita S
Blood; 1988 Feb; 71(2):473-9. PubMed ID: 2447984
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions.
Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
J Immunol; 2001 Dec; 167(12):6706-10. PubMed ID: 11739483
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
[TBL] [Abstract][Full Text] [Related]
20. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
